CW May 2004

category image Volume 13
Issue Number 5
May 2004
ISSN 10593802

Therion Biologics Initiates Phase III Trials with Pancreatic Cancer Vaccine

Therion Biologics Company, Cam-bridge, MA targets to launch a phase III trial of a cancer vaccine for the treatment of metastatic pancreatic cancer for chemotherapy-resistant patients this summer.
Go to Previous Page

Source & Additional Reading

(Study results) American Society of Clinical Oncology (ASCO) in New Orleans, June 7, 2004

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW May 2004

Purchase Downloadable Full-text PDF of Complete Issue: $20.00


Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login